PPBT

Purple Biotech
PPBT

Overview Fund Activity

10 hedge funds and large institutions have $1.04M invested in Purple Biotech in 2016 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
10
Holders Change
+7
Holders Change %
+233.33%
% of All Funds
0.27%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
1
Reduced
1
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
SM
Sabby Management
Florida
$725K
2
VKH
Virtu KCG Holdings
New York
$93K
3
Citadel Advisors
Citadel Advisors
Florida
$80K
4
MC
Menta Capital
California
$50K
5
FAAS
First Allied Advisory Services
California
$46K

Top Sellers

1
TRCT
Tower Research Capital (TRC)
New York
$2K
2
Citigroup
Citigroup
New York
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
SM
1
Sabby Management
Florida
$725K +$725K +1,163 New
VKH
2
Virtu KCG Holdings
New York
$93K +$93K +149 New
Citadel Advisors
3
Citadel Advisors
Florida
$80K +$80K +129 New
MC
4
Menta Capital
California
$50K +$50K +80 New
FAAS
5
First Allied Advisory Services
California
$46K +$46K +75 New
Jane Street
6
Jane Street
New York
$35K +$35K +57 New
UBS Group
7
UBS Group
Switzerland
$8K +$615 +1 +8%
Wells Fargo
8
Wells Fargo
California
$4K +$4K +7 New
TRCT
9
Tower Research Capital (TRC)
New York
$2K -$2K -2 -50%
Citigroup
10
Citigroup
New York
– -$1K -1 Closed